Carz R' Us

Help Us Put the Brakes on Breast Cancer!

BB_Road A

October is National Breast Cancer Awareness Month, an annual campaign to promote the awareness of and education about the disease that will affect 1-in-8 U.S. women during the course of their lives. 

We’re partnering with other independently owned shops across the country to take part in Brakes for Breasts, a fundraiser to support the Cleveland Clinic Breast Cancer Vaccine Fund. Throughout the month of October, customers will receive free brake pads with the purchase of brake rotors and labor. In addition, Carz R’ Us will donate ten percent of all brake services performed to the Cleveland Clinic Breast Cancer Vaccine Research Fund.

We’re doing this for our mothers, sisters, daughters, aunts and friends everywhere and we’re proud to be partnering with such an outstanding organization. 

What is Brakes for Breasts?

In its fifth year, Brakes for Breasts is a national fundraiser to support the Cleveland Clinic Breast Cancer Vaccine Fund. Last year, 174 Independently owned automotive repair shops across 32 states raised a combined total of $141,870 to support Dr. Vincent Tuohy’s efforts to develop a breast cancer vaccine.  It is important to note that 100 percent of funds raised as part of the Brakes for Breasts fundraiser are donated to the Cleveland Clinic Breast Cancer Vaccine Fund. 

About the Breast Cancer Vaccine Research Program

A team of researchers — led by Vincent Tuohy, Ph.D, in the Department of Immunology at Cleveland Clinic’s Lerner Research Institute — recently made high potential findings toward what could become the first-ever vaccine to prevent breast cancer.

The study found that a single vaccination with the protein α-lactalbumin prevents breast tumors from forming in mice, while also inhibiting the growth of already existing tumors.

Most attempts at cancer vaccines have targeted viruses, or cancers that have already developed. Yet, while viruses are recognized by the immune system as foreign invaders, cancer is not; it is an overdevelopment of the body’s own cells. Trying to vaccinate against this cell overgrowth would effectively be vaccinating against the recipient’s own body, destroying healthy tissue.

If proven successful in clinical testing, the strategy likely would be to vaccinate women over 40 — when breast cancer risk begins to increase and pregnancy becomes less likely. For younger women with a heightened risk of breast cancer, the vaccine may be an option to consider instead of preventive mastectomy.


About Dr. Vincent Tuohy, Ph.D:

Dr. Vincent Tuohy has spent more than 10 years working on a breast cancer vaccine that would both prevent the disease and keep it from recurring has secured enough funding to move the drug to clinical trials. Dr. Tuohy is an immunologist at the Cleveland Clinic’s Lerner Research Institute.

Posted in: Uncategorized

Leave a Comment (0) ↓